These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 4067379

  • 1. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB, Hood SA, Brown P, Cordy PE.
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT, Milliner DS, Johnson WJ.
    Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
    [Abstract] [Full Text] [Related]

  • 3. Elevated bone aluminum content in dialysis patients without osteomalacia.
    McCarthy JT, Kurtz SB, McCall JT.
    Mayo Clin Proc; 1985 May; 60(5):315-20. PubMed ID: 3990380
    [Abstract] [Full Text] [Related]

  • 4. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C, Armas JR, Palma A.
    Nefrologia; 2001 May; 21(2):174-81. PubMed ID: 11464651
    [Abstract] [Full Text] [Related]

  • 5. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J, Chaimovitz C, Abulfil A, Mostovlavsky M, Gazit D, Bab I.
    Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient].
    Yamagata K, Kobayashi M, Koyama A, Narita M, Amagai H, Ohno A, Yoshikawa S.
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):437-42. PubMed ID: 1875564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease.
    Mazzaferro S, Coen G, Ballanti P, Costantini S, Bondatti F, Giordano R, Manni M, Pasquali M, Perruzza I, Sardella D.
    Nephron; 1992 Apr; 61(2):151-7. PubMed ID: 1630538
    [Abstract] [Full Text] [Related]

  • 10. Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.
    Milliner DS, Nebeker HG, Ott SM, Andress DL, Sherrard DJ, Alfrey AC, Slatopolsky EA, Coburn JW.
    Ann Intern Med; 1984 Dec; 101(6):775-9. PubMed ID: 6208838
    [Abstract] [Full Text] [Related]

  • 11. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL, Maloney NA, Coburn JW, Endres DB, Sherrard DJ.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [Abstract] [Full Text] [Related]

  • 12. The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia.
    Finch JL, Bergfeld M, Martin KJ, Chan YL, Teitelbaum S, Slatopolsky E.
    Kidney Int; 1986 Sep; 30(3):318-24. PubMed ID: 3784278
    [Abstract] [Full Text] [Related]

  • 13. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB, Sherrard DJ, Alfrey AC, Ott S, Brickman AS, Miller NL, Maloney NA, Coburn JW.
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE, Johnson CA.
    Clin Pharm; 1985 Mar; 4(4):434-9. PubMed ID: 3899471
    [Abstract] [Full Text] [Related]

  • 16. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
    Charhon SA, Chavassieux P, Boivin G, Parisien M, Chapuy MC, Traeger J, Meunier PJ.
    Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dialysis osteodystrophy. A study involving 94 patients.
    Chan YL, Furlong TJ, Cornish CJ, Posen S.
    Medicine (Baltimore); 1985 Sep; 64(5):296-309. PubMed ID: 3839891
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
    Coburn JW, Norris KC.
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):12-21. PubMed ID: 3299588
    [Abstract] [Full Text] [Related]

  • 20. Case report 288: osteomalacia and secondary hyperparathyroidism (dialysis-induced), with aluminum deposition.
    Llewellyn CH, Resnik CS, Brower AC.
    Skeletal Radiol; 1984 Dec; 12(3):223-6. PubMed ID: 6494942
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.